Search

Displaying results 941 - 950 of 8010 in total
  1. Drug

    Metformin

    go.drugbank.com/drugs/DB00331
    ApprovedInvestigational

    [A176173] Another well-known benefit of this drug is modest weight loss, making it an effective choice for obese patients type II diabetes. … [A36559] Metformin was first approved in Canada in 1972,[A36552] and received subsequent FDA approval in the US in 1995.[L12207]

    Products: hovid-Metformin Powder for Oral Solution 500mg, MET BAY ® 500 TABLETAS RECUBIERTAS
  2. Drug

    Omega-3 fatty acids

    go.drugbank.com/drugs/DB11133
    ApprovedInvestigationalNutraceutical

    microalgae that is further consumed by phytoplankton, a source of diet for fish). … Omega-3 fatty acids are polyunsaturated fatty acids (PUFAs) with a double bond at the third carbon atom from the end of the carbon chain.

    Mixtures: K-OMEGASQUA (Softgel), OMEGA PLUS EMULSION FOR INFUSION
  3. Drug

    Afoxolaner

    go.drugbank.com/drugs/DB11369
    ExperimentalVet approved

    Mixtures: Nexgard Spectra 38mg/8mg Chewable Tablets for Dogs >7.5-15kg, Nexgard Spectra 9mg/2mg Chewable Tablets for Dogs 2-3.5kgProducts: NexGard 11mg chewable tablets for dogs 2-4kg, NexGard 136mg chewable tablets for dogs > 25-50kg
  4. Drug

    Oxtriphylline

    go.drugbank.com/drugs/DB01303
    Approved

    Oxtriphylline is the choline salt form of [theophylline]. … As such, oxytriphylline is indicated mainly for asthma, bronchospasm, and COPD (i.e. all the same indications as the other theophyllines).

    Categories: Drugs for Obstructive Airway Diseases
  5. Drug

    Carbocisteine

    go.drugbank.com/drugs/DB04339
    ApprovedInvestigational

    [A230993] Carbocisteine is currently not FDA or Health Canada approved, but is approved for use in Asia, Europe, and South America. … [L32383] Several licenses for this drug were withdrawn following serious and fatal paradoxical effects after carbocisteine therapy in children; respiratory dress, dyspnea, and cough aggravation were

    Products: MUKO-S FORT 375 MG TABLET , 20 ADET, MUKOTIK FORT 375 MG TABLET, 20 ADET
  6. Drug

    Pyrantel

    go.drugbank.com/drugs/DB11156
    ApprovedVet approved

    Pyrantel was initially described in 1965 by researchers from Pfizer who sought cyclic amidines with suitable pharmacokinetic properties (specifically, duration of action) for use as an anthelmintic drug … Pyrantel is mainly available in formulations for dogs and cats as the embonate salt, containing a 34.7% pyrantel base [L1900].

    Mixtures: Heartgard Plus Chewable Tablet for Dogs - Up to 25 lbs, Heartgard Plus Chewable Tablet for Dogs - 26 - 50 lbs
  7. Drug

    Zomepirac

    go.drugbank.com/drugs/DB04828
    ApprovedWithdrawn

    The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983.

  8. Drug

    D-threo-neopterin

    go.drugbank.com/drugs/DB02385
    Experimental

    (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of biopterin. … A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections.

    Synonyms: Neopterin D-threo-form
  9. Drug

    2-KETO-6-PHOSPHATE-D-GLUCONIC ACID, ALPHA-FURANOSE FORM

    go.drugbank.com/drugs/DB04663
    Experimental

    Synonyms: 2-KETO-6-PHOSPHATE-D-GLUCONIC ACID, ALPHA-FURANOSE FORM
  10. Drug

    L-2-amino-4-methoxy-cis-but-3-enoic acid

    go.drugbank.com/drugs/DB03611
    Experimental

    Synonyms: L-2-amino-4-methoxy-cis-but-3-enoic acid